Effects of different n-6/n-3 polyunsaturated fatty acids ratios on lipid metabolism in patients with hyperlipidemia: a randomized controlled clinical trial

Abstract

Background and aimsIntake of n-3 polyunsaturated fatty acids (PUFA) is helpful for cardiometabolic health. It improves lipid metabolism, and increasing n-3 PUFA is often considered beneficial. However, the role of n-6/n-3 in the regulation of lipid metabolism has been much debated. Therefore, this study was performed on the effect of different proportions of n-6/n-3 diet on lipid metabolism, and quality of life in patients with hyperlipidemia, aiming to explore appropriate proportions of n-6/n-3 to provide the theoretical basis for the development and application of nutritional blended oil in the future.MethodsThese 75 participants were randomized and assigned into three groups, which received dietary oil with high n-6/n-3 PUFA ratios (HP group: n-6/n-3 = 7.5/1), dietary oil with middle n-6/n-3 PUFA ratios (MP group: n-6/n-3 = 2.5/1) or low n-6/n-3 PUFA ratios (LP group: n-6/n-3 = 1/2.5). All patients received dietary guidance and health education were monitored for hyperlipidemia. Anthropometric, lipid and blood glucose parameters and quality of life were assessed at baseline and 60 days after intervention.ResultAfter 60 days, high-density lipoprotein cholesterol (HDL-c) level was increased (p = 0.029) and Total cholesterol (TC) level was decreased (p = 0.003) in the MP group. In the LP group, TC level was decreased (p = 0.001), TG level was decreased (p = 0.001), but HDL-c level was not significantly increased. At the end of intervention, quality of life’ score was improved in both MP and LP groups (p = 0.037).ConclusionDecreasing the intake of edible oil n-6/n-3 ratio can improve blood lipids and quality of life. This is significant for the prevention of cardiovascular disease (CVD). It is also essential to note that an excessive reduction of the n-6/n-3 ratio does not further improve the blood lipid metabolism. In addition, the application of perilla oil in nutritional blended oil has particular significance.Clinical trial registrationhttps://www.chictr.org.cn/indexEN.html, identifier ChiCTR-2300068198.

Sustainable Transformation of Two Algal Species of Different Genera to High-Value Chemicals and Bioproducts

“…It is hypothesized that all PUFAs in the diet can depress low-density lipoprotein cholesterol (LDL-C) and lower serum cholesterol levels, whereas all SFAs contribute to high levels of the latter. The results of a recent clinical study confirm the positive influence of PUFAs on high-density lipoprotein cholesterol (HDL-C) levels and total cholesterol—the levels of the former were increased, while those of the latter decreased [ 20 ].…”

Cellular Basis of Adjuvant Role of n-3 Polyunsaturated Fatty Acids in Cancer Therapy: Molecular Insights and Therapeutic Potential against Human Melanoma

“…Another challenge is the scarcity of human studies on supplementation with n-3 PUFA in melanoma and other cancers. Over the past decades, there has been a shift in dietary patterns in the current human population compared to our ancestors, and modulating the n-6/n-3 ratio has been considered an intriguing point in the research field across various pathologies [181][182][183][184]. However, a randomized controlled trial showed that supplementation with n-3 PUFA did not result in a lower incidence of major cardiovascular events or cancer than placebo [185].…”

The serum metabolic profile plays a role in mediating the regulatory impact of gut microbiota and its metabolites on susceptibility to obesity in mice

“…(Van Name et al, 2020) The ratio of n-6/n-3 PUFA is known to play a signi cant role in lipid metabolism regulation. (Yang et al, 2023) Recent clinical studies have demonstrated that reducing the n-6/n-3 PUFA ratio can lead to lower lipid levels and weight loss. These ndings may help explain the inverse correlation observed between EPA and AA in mouse phenotypes.…”